AstraZeneca PLC
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
Chief Executive Officers of pharmaceutical companies testify before the Senate Finance Committee on “Drug Pricing in America: A Prescription for Change, Part II” February 26, 2019 in Washington, DC. From left to right are Richard A. Gonzalez, chairman and CEO of AbbVie Inc; Pascal Soriot, executive director and CEO of AstraZeneca; Giovanni Caforio, chairman of […]
Read More
Pro Talks: This fund supervisor is betting large on the getting old concept, which include one ‘huge’ chance
The world’s populace is receiving more mature — and it truly is developing major financial commitment opportunities, according to Pacific Asset Management’s Dani Saurymper. Be a part of CNBC’s Arabile Gumede as he discusses with Saurymper how to engage in the prolonged-expression aging theme on Professional Talks . Saurymper manages the Pacific Longevity & Social […]
Read More
FDA advisors recommend AstraZeneca, Sanofi antibody to protect babies from RSV
Narisara Nami | Moment | Getty Images A panel of independent advisors to the Food and Drug Administration unanimously recommended Thursday that the antibody nirsevimab be approved for use to protect infants from respiratory syncytial virus, the leading cause of hospitalization among newborns. If the FDA approves nirsevimab, the antibody would become the first medical […]
Read More
ASCO conference will put the focus on the fight against cancer. These stocks are in the spotlight
Developments in cancer research will be in the spotlight as the American Society of Clinical Oncology hosts the world’s biggest cancer research conference in Chicago, starting Thursday. Investors have already caught a glimpse of the topics that will be discussed but many are eager to hear the details behind the abstracts, and no doubt there […]
Read More
Report quantity of British firms pessimistic about China organization, survey reveals
See of the central organization district skyline at sunset in Beijing, China. Sheng Peng | Visible China Group | Getty Illustrations or photos A history quantity of British providers are pessimistic about doing business enterprise in China and are taking a “wait around and see method,” in accordance to a study by the British Chamber […]
Read More
Citi names its major biotech and pharma stock picks, offering one approximately 90% upside
The health care sector outperformed in Europe, India and China previous thirty day period, according to Citi, which named its major picks around the globe. Europe’s pharma sector appears to be significantly robust, the financial institution mentioned in a May 4 take note, with European big caps observing consensus earnings updates in April and favourable […]
Read More
This worldwide professional genuine-estate stock is set to increase by 60%, Jefferies states
Jefferies expects shares of U.K.-targeted commercial authentic-estate stock Life Science REIT to rise by far more than 60% over the upcoming 12 months. The expense bank’s prediction arrives at a time when the world wide professional true estate market place has found price ranges drop sharply above the previous 12 months . In the U.K., […]
Read More
As Brits reel from a cost-of-living crisis, the UK stock market quietly booms to an all-time high
The sun rises over the city on Feb. 6, 2023 in London, United Kingdom. Leon Neal | Getty Images News | Getty Images LONDON — The U.K. is facing the weakest growth prospects in the G-7 and a catalogue of cost-of-living pressures that are pushing the poorest into crisis and intensely squeezing the budgets of […]
Read More
As demand from customers for Covid vaccines falls, AstraZeneca strains up ‘blockbuster’ merchandise for 2023
AstraZeneca has “blockbuster” assignments in growth that are established to make billions of dollars, according to its CFO. BSIP / Contributor / Getty Photographs Desire for Covid-19 vaccines has dropped as the pandemic enters its fourth calendar year, but AstraZeneca states it has “blockbuster” assignments in enhancement that are established to make billions of dollars. […]
Read More
FDA withdraws Covid antibody treatment Evusheld because it’s not effective against 93% of subvariants
Evusheld (tixagevimab and cilgavimab) injection, a new COVID-19 treatment that people can take before becoming symptomatic. (Chris Sweda/Chicago Tribune/Tribune News Service via Getty Images) Chris Sweda | Tribune News Service | Getty Images The Food and Drug Administration on Thursday pulled its authorization for AstraZeneca‘s Evusheld, an antibody injection that people with weak immune systems […]
Read More